Informatie:
Fout:
ID
32867
Beschrijving
Shiga Progression of Diabetes, Nephropathy and Retinopathy; ODM derived from: https://clinicaltrials.gov/show/NCT00846716
Link
https://clinicaltrials.gov/show/NCT00846716
Trefwoorden
Versies (1)
- 17-11-18 17-11-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
17 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Type 2 Diabetes Mellitus NCT00846716
Eligibility Type 2 Diabetes Mellitus NCT00846716
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00846716
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
less than 8.0% in hba1c
boolean
C0474680 (UMLS CUI [1])
Urine albumin/creatinine ratio measurement
Item
less than 300 mg/g cr of urinary albumine level
boolean
C0455271 (UMLS CUI [1])
Sulfonylurea | Biguanide
Item
concomitant therapy with su and/or biguanide
boolean
C0038766 (UMLS CUI [1])
C0005382 (UMLS CUI [2])
C0005382 (UMLS CUI [2])
Hypertensive disease Untreated | Hypertensive disease | Angiotensin II receptor antagonist | Angiotensin-Converting Enzyme Inhibitors
Item
untreated hypertension and hypertension treated with arb or acei
boolean
C0020538 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2])
C0521942 (UMLS CUI [3])
C0003015 (UMLS CUI [4])
C0332155 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2])
C0521942 (UMLS CUI [3])
C0003015 (UMLS CUI [4])
Heart failure
Item
history of heart failure and concomitant heart failure
boolean
C0018801 (UMLS CUI [1])
Thiazolidinediones
Item
history of administration of tzd agent
boolean
C1257987 (UMLS CUI [1])
Liver Dysfunction Severe | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
severe hepatic dysfunction with more than 3 times higher than upper limit of normal range of got, gpt or rgpt
boolean
C0086565 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Renal dysfunction Severe | Serum creatinine raised
Item
severe renal dysfunction with more than 2.5 of cr
boolean
C3279454 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0700225 (UMLS CUI [2])
C0205082 (UMLS CUI [1,2])
C0700225 (UMLS CUI [2])
Adverse events Thiazolidinediones Related
Item
history of ae with tzd agent
boolean
C0877248 (UMLS CUI [1,1])
C1257987 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C1257987 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
Insulin regime
Item
insulin treatment
boolean
C0557978 (UMLS CUI [1])
Urinary tract infection
Item
concomitant urinary track infection
boolean
C0042029 (UMLS CUI [1])